Celestica (NYSE:CLS) Upgraded at Wolfe Research

Wolfe Research upgraded shares of Celestica (NYSE:CLS) (TSE:CLS) to a strong-buy rating in a report issued on Tuesday,Zacks.com reports.

CLS has been the topic of a number of other reports. Aletheia Capital increased their price objective on Celestica from $330.00 to $410.00 and gave the company a “buy” rating in a research report on Tuesday, January 20th. Zacks Research upgraded Celestica from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 5th. New Street Research set a $400.00 price objective on Celestica in a research report on Wednesday, October 29th. Canadian Imperial Bank of Commerce boosted their price objective on Celestica from $315.00 to $400.00 and gave the stock an “outperform” rating in a report on Wednesday, October 29th. Finally, JPMorgan Chase & Co. raised their target price on shares of Celestica from $295.00 to $360.00 and gave the company an “overweight” rating in a research note on Wednesday, October 29th. Two analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $356.59.

Celestica Trading Down 0.0%

CLS opened at $291.37 on Tuesday. Celestica has a 1-year low of $58.05 and a 1-year high of $363.40. The stock has a market capitalization of $33.52 billion, a PE ratio of 40.58 and a beta of 1.86. The company has a current ratio of 1.47, a quick ratio of 0.88 and a debt-to-equity ratio of 0.37. The firm has a 50-day moving average price of $300.30 and a two-hundred day moving average price of $277.98.

Insider Transactions at Celestica

In other news, insider Yann L. Etienvre sold 86,229 shares of the business’s stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $287.45, for a total value of $24,786,526.05. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, President Jason Phillips sold 100,000 shares of the company’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $308.92, for a total value of $30,892,000.00. Following the transaction, the president directly owned 12,584 shares of the company’s stock, valued at $3,887,449.28. This represents a 88.82% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 297,923 shares of company stock valued at $88,027,459 over the last three months. 0.52% of the stock is currently owned by corporate insiders.

Institutional Trading of Celestica

Hedge funds and other institutional investors have recently made changes to their positions in the business. Pinney & Scofield Inc. increased its stake in Celestica by 20.0% in the 3rd quarter. Pinney & Scofield Inc. now owns 180 shares of the technology company’s stock valued at $44,000 after buying an additional 30 shares during the last quarter. LeConte Wealth Management LLC boosted its position in Celestica by 3.5% during the fourth quarter. LeConte Wealth Management LLC now owns 1,001 shares of the technology company’s stock valued at $296,000 after purchasing an additional 34 shares during the last quarter. MassMutual Private Wealth & Trust FSB grew its stake in Celestica by 42.5% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 124 shares of the technology company’s stock valued at $31,000 after purchasing an additional 37 shares in the last quarter. World Equity Group Inc. increased its position in shares of Celestica by 1.7% during the 3rd quarter. World Equity Group Inc. now owns 2,263 shares of the technology company’s stock worth $558,000 after purchasing an additional 38 shares during the last quarter. Finally, Terra Nova Asset Management LLC increased its position in shares of Celestica by 2.3% during the 4th quarter. Terra Nova Asset Management LLC now owns 1,686 shares of the technology company’s stock worth $498,000 after purchasing an additional 38 shares during the last quarter. 67.38% of the stock is currently owned by institutional investors and hedge funds.

Celestica News Summary

Here are the key news stories impacting Celestica this week:

• Positive Sentiment: Wolfe Research upgraded Celestica to a “strong‑buy,” supporting buy‑side interest and momentum in the shares. Wolfe Research upgrade reported by Zacks
• Positive Sentiment: Celestica raised its 2026 outlook citing stronger AI/data‑center demand, which underpins revenue and capex visibility—this guidance lift is a clear catalyst for longer‑term re‑rating. Celestica Lifts 2026 Outlook On AI Data Center Demand And Risks
• Positive Sentiment: Analyst/commentary pieces highlight operational strength: Q4 marked Celestica’s 17th consecutive dual earnings beat with strong EPS growth and a robust balance sheet—evidence that execution and AI tailwinds are accelerating. Celestica: I Was Wrong, Upgrading On Strong Support
• Positive Sentiment: Bullish deep‑dive coverage frames the company’s $1B CAPEX cycle as a growth signal tied to hyperscaler AI demand and argues CLS is transitioning from EMS to a mission‑critical AI infrastructure partner—these narratives support higher future multiples if growth materializes. Celestica: Why The $1B CAPEX Surge Is A Buy Signal, Not A Red Flag
• Positive Sentiment: Zacks added CLS to its Rank #1 (Strong Buy) / momentum lists, which can attract quant/momentum flows and retail attention. Best Momentum Stocks to Buy for February 18th
• Neutral Sentiment: Media pieces examine analyst optimism and whether rating changes matter long term; useful context but not an immediate fundamental change. Wall Street Bulls Look Optimistic About Celestica (CLS): Should You Buy?
• Negative Sentiment: Pomerantz LLP issued an investor alert announcing an investigation into Celestica on behalf of investors—this raises short‑term legal/PR risk and can pressure the stock while uncertainty exists. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Celestica Inc. – CLS

About Celestica

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.